Prenetics, NASDAQ Health Sciences Company, Partners with David Beckham

Core Insights - David Beckham has become a strategic investor in Prenetics, co-founding a new health and wellness brand named IM8, which will focus on innovative consumer health products [2] - Beckham's involvement is seen as a transformative opportunity for Prenetics in global health innovation and wellness, aligning with the company's core principles [2] Company Overview - Prenetics (NASDAQ:PRE) is a leading health sciences company dedicated to advancing consumer and clinical health, with a consumer initiative led by the new brand IM8 [5] - The clinical division of Prenetics includes Insighta, a $200 million joint venture focused on multi-cancer early detection technologies, and ACT Genomics, which has achieved FDA clearance for comprehensive genomic profiling of solid tumors [5] Strategic Partnership - Beckham's partnership with Prenetics is expected to enhance the company's mission of making health accessible to all, reflecting his values of discipline, teamwork, and health [2] - The collaboration aims to leverage Beckham's vision and passion for health to contribute meaningfully to the consumer health and wellness industry [2] Innovations and Impact - Prenetics is recognized for its significant innovations, including non-invasive prenatal testing discovered by Professor Dennis Lo, which is used by over 15 million expectant mothers annually in 90 countries [9] - The company is also focused on early cancer detection technologies, which have the potential to improve survival rates through earlier intervention [9]